GLSI Greenwich LifeSciences Inc

$GLSI When we cracked $20 on Friday, we closed at $18.99. Today we cracked it again and closed at $19.48, so maybe next time we hold $20 and don't look back. $20.31 was our highest price since 7/16 and $19.48 is our highest close since 7/15. We will get news soon enough and any memory below $25 will seem like a bad dream. Until then, happy for the general uptrend, even if the close isn't always pretty. Let's do it again tomorrow.

$GLSI Only 7 weeks until Bio Europe. (FYI, it's been 6 weeks since this comment): CEO Snehal Patel commented, "We attended and presented at the BIO conference in June 2026 and plan to attend the BIO-Europe conference later this year, where strategic and financing transactions can be originated or concluded. With the further derisking of the Phase III clinical trial, more than doubling of enrollment and event rate, interest from leading clinicians and hospitals in up to 200 sites in the US and Europe, screening of over 1,500 patients, and the transformation of the interim analysis into a big pharma like study similar in design to recent large breast cancer studies, we are expecting a continued up-tick in the quantity and seriousness of such discussions."

$GLSI I am speculating that if the trial is successful the stock will eclipse the all-time high of $158.

$GLSI I follow here and post as much as anybody, but at this point, the day-to-day ups and downs are meaningless without news. With approximately 5 weeks to go until Bio Europe, be in or be out, say your prayers for good news, and hope you are on the right side of things when everything unfolds. Doesn't mean we will have all the answers on or before Bio Europe, but we will have something by then.

$GLSI from what I have seen our CEO has been methodical, determined, and has put his money where his mouth is for years and years, not simply symbolic - and has been very gutsy by locking up executive stocks, and if they were executives who thought this was a farce, they would have left - we have countries beyond countries now involved with the testing, and patients after patients volunteering - so yeah I feel pretty good and yeah, I’m pretty heavily invested. I could pull it out today breakeven but I’m good. I’m not buying and selling as a day trader because I’m not looking for nickels and dimes from this one. I know what I own. PERIOD

$GLSI just went to check pictures that GLSItothemoon is inaccurately posting. Everyone should be reporting him for misrepresentation. He is obviously a short. Oh and he was probably blocked before because all of a sudden he has a new profile dated Sept 2026. 🤡 Do your own due diligence. Look at the company’s website and Press releases before making your own judgement. Be informed. Don’t blindly follow folks with their agendas. 55X,Bernard,HarvardMBA are 🤡 that people see right thru. Do your own proper analysis on any given stock. NIA.

$GLSI Not only is the share price disconnected from reality (market cap of $250M, 10% drop today on no volume or news) but the borrowing costs are disconnected as well. Current Short interest is the second largest on record, yet the cost to borrow has plunged to below 20%. In December when the short interest hit the highest ever, the cost to borrow was well into triple digits. So many things don’t make sense right now. I hope we get some real news that will get us back above $20 soon.

$GLSI Nothing fake about this participation: U.S. Phase 3 alone, positive. U.S. + European countries, very positive. 170–180 U.S./European sites, substantial. FDA + EMA acceptance of unified protocol, very substantial... Faster enrollment, very important for timing... Strong international enrollment.

$GLSI did anyone see the news that shot Moderna up today? Apparently the NIH is going to fund cancer vaccine research. I hope Mr. Patel can get some of that funding.

$GLSI the advantage of having a CEO with so many shares in the company (and who has continued to buy) means he needs to sell the company in order to realise his wealth. Snehal has run the company extremely well since IPO. credit where credit is due.

$GLSI Picked up another 1k at 14.5. Bout time for news on this one. 🤔 I think we will be hearing some updates soon....

$GLSI this is generally a very small clean message board. Without pumping of other stocks. Unsolicited investment advice usually grounds for instant block and report. Keep it clean junior

$GLSI ZERO near term catalyst and isn't aggressively undervalued. Holders need 1 interim superiority because partnership or buyout near term not happening. Let's track few biotechs vs GLSI.... ZURA small % hold GLSI $15 NVCT $18 ABVX $88 ZURA $4

$GLSI if our vaccine works and is 95% + efficacious, insurance companies will look to first cover GLSI and not MRNA as standard course of treatment

$GLSI $SLN owning biotech in a rising rate environment is like getting kicked in the nuts. The fundamentals and science will never prevail. Long both GLSI &SLN.

$GLSI if you think of your investment as a partnership instead of get rich quick plan your level of patience will grow exponentially.

$GLSI Should hit $20 today. And the immune nit even a fraction of the interim data. I have a buddy in a wealth fund acclimating on a personal level privately. He uses his company resources for DD. He likes our chances. Let’s just say he is a bit late to the game compared to some of us, but of course he has a shit ton of shares. Don’t for get the best DD that crappy traders ignore: 👇👇👇

$GLSI Absolutely zero reason for longs to panic today. Volume is still persistently low. And, anyone selling on news of that Tukysa combination is either short or uninformed retail. A drug that controls established metastatic cancer does not automatically compete with a vaccine designed to prevent that cancer from recurring in the first place. Moreover, tucatinib + trastuzumab + pertuzumab has a substantial side-effect burden. Most patients in the maintenance trial experienced some adverse effect, and serious side effects were not rare. The two biggest concerns are liver toxicity and diarrhea.

$GLSI We didn’t beat $XBI today, but the real prize is when they release data. Up the past 5 days:

$GLSI This is why we can’t have nice things. 20,000 shares wiped out the gains from yesterday. Wake me when news comes out b